Answers are grounded in this paper and cite their sources.
Funding was provided by Foundation Medicine Inc., the Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, the Viragh Foundation, the National Cancer Institute Specialized Program of Research Excellence (SPORE) in Gastrointestinal Cancers (P50 CA062924), the NIH Center Core Grant (P30 CA006973), the Norman & Ruth Rales Foundation, and the Conquer Cancer Foundation.
No takes yet. Share an insight, caveat, or question.
Yarchoan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: